Core Insights - Weigao Co., Ltd. reported a revenue of 1.106 billion yuan for the first three quarters of 2024, representing a year-on-year increase of 2.12% [1] - The net profit attributable to shareholders reached 207 million yuan, marking a year-on-year increase of 26.24% [1] - Basic earnings per share stood at 0.52 yuan [1] Revenue and Profit Performance - The company experienced stable execution of bulk procurement in the orthopedic sector during the reporting period [1] - The market share of leading domestic brands in the orthopedic field continued to rise [1] Strategic Initiatives - The company is undergoing a transformation in its sales model, focusing on professional departments for business unit division [1] - This transformation aims to optimize and upgrade the marketing structure, leading to increased specialization and flexibility within the sales team [1] - Enhanced professional service levels in clinical settings have contributed to sustained growth in revenue and sales volume across product lines [1]